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A total of 145 penicillin-nonsusceptible Streptococcus pneumoniae strains were isolated from young carriers
in Greece and analyzed by antibiotic susceptibility testing, serotyping, restriction fragment end labeling (RFEL),
and penicillin-binding protein (PBP) genotyping. The serotypes 23A and 23F (54%), 19A and 19F (25%), 9V
(5%), 15A, 15B, and 15C (4%), 6A and 6B (4%), and 21 (4%) were most prevalent in this collection. Fifty-three
distinct RFEL types were identified. Sixteen different RFEL clusters, harboring 2 to 32 strains each, accounted
for 82% of all strains. Eight of these genetic clusters representing 60% of the strains were previously identified
in other countries. A predominant lineage of 66 strains (46%) harboring five RFEL types and the serotypes 19F
and 23F was closely related to the pandemic clone Spain23F-1 (genetic relatedness of >85%). Another lineage,
representing 11 strains, showed close genetic relatedness to the pandemic clone France9V-3. Another lineage of
8 serotype 21 strains was Greece specific since the RFEL types were not observed in an international collection
of 193 genotypes from 16 different countries. Characterization of the PBP genes pbp1a, pbp2b, and pbp2x re-
vealed 20 distinct PBP genotypes of which PBP type 1-1-1, initially observed in the pandemic clones 23F and
9V, was predominantly present in 11 RFEL types in this Greek collection of penicillin-nonsusceptible strains
(55%). Sixteen PBP types covering 52 strains (36%) were Greece specific. This study underlines the strong con-
tribution of penicillin-resistant international clones to the prevalence and spread of penicillin-nonsusceptible
pneumococci among young children in Greece.
Streptococcus pneumoniae is worldwide a common cause of
invasive diseases such as meningitis, bacteremia, and pneumo-
nia and of upper respiratory tract infections (1). Pneumococci
are often part of the normal nasopharyngeal flora. Especially
young children and elderly people are at risk of becoming
colonized with S. pneumoniae. The colonization risk increases
where crowding occurs, e.g., in day care centers, hospitals, and
nursing homes (23, 30, 31). Although a positive correlation
between colonization with pneumococci and acute otitis media
has been found (12, 36), a relation between pneumococcal
carriage and invasive disease has not yet been proven.
Since the late 1970s and 1980s, antibiotic resistance among
pneumococci has become an emerging problem. Several (mul-
ti)drug-resistant clones have rapidly spread throughout various
European countries, North and Latin America, and Asia (2,
18, 20). Some of these clones were initially discovered in Spain,
where so far the prevalence of penicillin resistance has reached
levels of up to 60% (4). The most striking example is the spread
of the pandemic multidrug-resistant clone 6B from Spain to
Iceland in the late 1980s, where until 1988 no drug resistance
among S. pneumoniae isolates had been reported. From 1989
to 1992 penicillin resistance rose steeply from 2.3 to 17% (39).
In 1993, the resistance level among pneumococcal isolates in
Iceland reached 20%, of which the vast majority was associated
with the serogroups 6, 19, and 23 (25). In 1991, Munoz et al.
have reported the intercontinental spread of a multidrug re-
sistant S. pneumoniae clone of serotype 23F from Spain to the
United States (29). Since then this clone, recently designated
pandemic clone Spain23F-1 (http://www.wits.ac.za/pmen/pmen
.htm) has rapidly spread throughout the United States (27).
Finally, Gasc et al. have described in 1995 the spread of a
penicillin-resistant pneumococcal clone of serotype 9V (pan-
demic clone France9V-3) from Spain to France (14). Through-
out the years these clones have been identified in many
countries in different parts of the world (10, 20, 42). In
addition, novel drug-resistant clones have been reported in
France, former Czechoslovakia, Spain, Hungary, Japan, South
Africa, the United States, Chile, England, etc. which tend to
spread in a nationwide manner (6, 13, 16, 17, 19, 35, 37, 45).
The risk for colonization with and spread of antibiotic-resistant
strains is related to younger-age children, occurrence of refrac-
tory middle ear infections, previous antibiotic consumption,
and day care attendance (9, 28, 32).
In Greece, the emergence of antibiotic resistance among
pneumococcal isolates was recognized in the mid 1990s (41).
During the period December 1995 through February 1996,
53% of the pneumococci isolated from healthy carriers attend-
ing day care centers appeared to be resistant to one or more
antibiotics, while 29% of these isolates were penicillin nonsus-
ceptible (41). In a recent study in which 2,448 infants and
toddlers were screened during a 2-year period (1997 to 1999)
for pneumococcal carriage, 16% of the pneumococci demon-
strated reduced susceptibility to penicillin (40; G. Syrogianno-
poulos, I. Grivea, G. Katopodis, and N. Beratis, unpublished
data). The aim of the current study was to identify the molec-
ular epidemiological nature of the penicillin-nonsusceptible
pneumococci isolated in Greece. For this purpose, molecular
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analysis was performed on penicillin-nonsusceptible isolates of
the two Greek studies. A total of 145 (multi)resistant pneu-
mococcal isolates collected from both studies were character-
ized by drug susceptibility testing, serotyping, restriction frag-
ment end labeling (RFEL), and penicillin-binding protein
(PBP) genotyping.
MATERIALS AND METHODS
Bacteriology. Penicillin-nonsusceptible S. pneumoniae strains were isolated
from the nasopharynx of 338 children attending seven day care centers in the city
of Patras, Southwestern Greece, from December 1995 to February 1996 and
from 2,448 children under the age of 2 years visiting health care centers in
Southern and Central Greece from February 1997 to February 1999. Bacterio-
logical diagnosis and susceptibility testing were carried out at the Laboratory of
the Division of Pediatric Infectious Disease of the University of Patras, Patras,
Greece. The bacteriological methods and serotyping have been described previ-
ously (40, 41). Molecular analysis was performed on 92% of the penicillin-
nonsusceptible isolates, i.e., 34 strains collected from seven day care centers in
Patras and 111 strains collected from 12 different provinces in Central and
Southern Greece. In addition, the Greek isolates were compared with an inter-
national collection of pneumococcal strains representing 193 distinct RFEL
types originating from 16 different countries in America, Europe, Africa, and
Asia (M. Sluijter, unpublished observations), in which the international clones
pandemic clone Spain23F-1, pandemic clone France9V-3, and pandemic clone
Spain6B-2 are present (http://www.wits.ac.za/pmen/pmen.htm).
RFEL analysis. Typing of the 145 pneumococcal strains by RFEL analysis was
performed as described by van Steenbergen et al. (44) and as adapted by Her-
mans et al. (22). Briefly, purified pneumococcal DNA was digested by the
restriction enzyme EcoRI. The DNA restriction fragments were end labeled at
72°C with [a-32P]dATP using DNA polymerase (Goldstar; Eurogentec, Seraing,
Belgium). The radiolabeled fragments were denatured and separated electro-
phoretically on a 6% polyacrylamide sequencing gel containing 8 M urea. Sub-
sequently, the gel was transferred onto filter paper, vacuum dried (HBI, Saddle-
brook, N.Y.), and exposed for various times at room temperature to ECL
Hyperfilms (Amersham, Bucks, United Kingdom).
BOX PCR fingerprinting. Typing of the 145 pneumococcal strains by BOX
PCR fingerprinting was performed as described by van Belkum et al. (43).
Briefly, 50 ng of pneumococcal DNA was amplified by PCR (4 min at 94°C
[predenaturation]; 40 cycles of 1 min at 94°C, 1 min at 60°C, and 2 min at 74°C;
and 2 min at 74°C [extension]), using primer BOX-A (59-ATACTCTTCGAAA
ATCTCTTCAAAC), which was designed from the primary structure of the
pneumococcal BOX repeat motif. The amplified products were separated on a
1.5% agarose gel. Gels were stained with ethidium bromide, and the banding
patterns were evaluated visually.
PBP genotyping. Genetic polymorphism of the penicillin resistance genes
pbp1a, pbp2b, and pbp2x of the penicillin-nonsusceptible isolates was investigated
by restriction fragment length polymorphism (RFLP) analysis as described pre-
viously (20). Briefly, we amplified the genes by PCR. The primers used to amplify
the genes pbp1a, pbp2b, and pbp2x were described previously (7, 11). The am-
plification products (5 ml) were digested by restriction endonuclease HinfI and
separated by agarose gel electrophoresis. Gels were scanned and analyzed by the
Geldoc 2000 system (Bio-Rad). The different PBP genotypes received a three-
number code (e.g., 6-12-34) referring to the RFLP patterns of the genes pbp1a
(6), pbp2b (11), and pbp2x (33), respectively.
Computer-assisted analysis of the DNA banding patterns. The RFEL types
were analyzed using the Windows version of the Gelcompar software version 4
(Applied Maths, Kortrijk, Belgium) after imaging of the RFEL autoradiograms
using the Image master DTS (Pharmacia Biotech, Uppsala, Sweden). To this
end, the DNA fragments in the molecular size range of 160 to 400 bp were
explored. The DNA banding patterns were normalized using pneumococcus-
specific bands present in the RFEL banding patterns of all strains. Comparison
of the banding patterns was performed by unweighted-pair-group method using
arithmetic averages (34) and using the Jaccard similarity coefficient applied to
peaks (38). Computer-assisted analysis and methods and algorithms used in this
study were carried out according to the instructions of the manufacturer of
Gelcompar. A tolerance of 1.2% in band position was applied during comparison
of the DNA patterns. For evaluation of the genetic relatedness of the isolates, we
used the following definitions: (i) strains of particular RFEL type are 100%
identical by RFEL analysis; (ii) a RFEL cluster represents a group of RFEL
types that differs in only one band (ca. .95% genetic relatedness); and (iii) an
RFEL lineage represents a group of RFEL types that differs in ,4 bands (ca.
.85% genetic relatedness).
Statistical analysis. For statistical analysis of the results, we used the Fisher
exact test.
RESULTS
A total of 145 penicillin-nonsusceptible pneumococcal strains
were analyzed using serotyping, RFEL, and PBP genotyping.
Serotyping revealed 12 different serotypes, namely, 23F (52%);
23A (2%); 19F (15%); 19A (10%); 9V (5%); 15A, 15B, and
15C (4%); 6A (2%); 6B (1%); 21 (4%); 14 (2%); 22 (1%); and
33F (1%) (40, 41; Syrogiannopoulos et al., unpublished).
RFEL analysis divided the strains into 53 distinct RFEL ge-
notypes (Fig. 1). Sixteen genetic clusters were observed in this
collection of strains, representing 82% of the strains and vary-
ing in size from 2 to 32 strains. The genetic relatedness within
these clusters was confirmed by BOX PCR (43) (data not
shown). Five of the sixteen clusters contained two serotypes,
while one of the clusters harbored three different serotypes.
We compared the 53 Greek RFEL types with our international
library in which 193 RFEL genotypes of pneumococci from 16
different countries are present (M. Sluijter, unpublished ob-
servations). Six of the clusters representing 60% of the isolates
were previously seen. To analyze the genetic heterogeneity in
the penicillin resistance genes, we performed PBP genotyping.
Twenty distinct PBP genotypes were observed (Table 1). PBP
genotype 1-1-1, initially observed in the pandemic clones 23F
and 9V, was most predominantly observed in this Greek col-
lection; 81 strains representing 13 distinct RFEL types shared
this penicillin resistance genotype.
Clusters IX and X were the most predominantly observed
clusters and consisted of 31 (21%) and 32 strains (22%), re-
spectively (Fig. 1, Table 1). Both clusters belonged to one pre-
dominant lineage of 66 genetically related strains, representing
five RFEL types and harboring the serotypes 23F and 19F. This
lineage was closely related to the pandemic clone Spain23F-1
(genetic relatedness of $90%) which is widely spread all over
the world (8, 26, 42). All strains belonging to this lineage showed
resistance to penicillin, chloramphenicol, tetracycline, and sul-
famethoxazole-trimethoprim. In addition, cluster I was also
resistant to erythromycin and clindamycin. Similar to the char-
acteristics of the pandemic clone Spain23F-1, this lineage in-
variably demonstrated PBP genotype 1-1-1.
The second lineage representing cluster VII contained 10
strains of serotypes 19F (Fig. 1, Table 1). Cluster VII was ob-
served previously in The Netherlands, Thailand, and Vietnam
and showed reduced susceptibility to penicillin, tetracycline,
erythromycin and, in most cases, to sulfamethoxazole-trimetho-
prim. This cluster had another common feature since the ge-
netic analysis of pbp1a by PBP genotyping of the vast majority
of the strains was not applicable. Consequently, the PBP ge-
notype of the majority of these strains was 0-3-30. Interestingly,
this observation is in agreement with the genetically related
strains present in the international data library.
The third lineage representing 12 strains and the clusters III,
IV, and V displayed serotype 19A (Fig. 1, Table 1). These
strains did not cluster with isolates from the international li-
brary and their PBP genotype did not match with any of the
PBP genotypes present in the international library. All strains
displayed the pbp1a and pbp2b genotype 2-2 that matched with
the majority of the penicillin-susceptible pneumococci ana-
lyzed so far (Sluijter, unpublished). We observed alterations in
the PBP profile of pbp2x, resulting in the genotypes 2-2-75 and
2-2-80. These PBP genotypes invariably corresponded to inter-
mediate resistance to penicillin only.
The fourth lineage represented the clusters XV (two strains)
and XVI (nine strains) and harbored the serotypes 9V, 14,
and 23A (Fig. 1, Table 1). These clusters corresponded to the
pandemic clone France9V-3. All strains showed the PBP geno-
type 1-1-1 and were invariably resistant to penicillin, sulfame-
thoxazole-trimethoprim and, in some strains, to chloramphen-
icol and tetracycline.
The fifth lineage represented the clusters XIII (serotype 21;
six strains) and XII (serogroup 23F; two strains) (Fig. 1, Table
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FIG. 1. Dendrogram of the 53 RFEL types observed among 145 penicillin-nonsusceptible pneumococcal isolates from the nasopharynxes of Greek children.
Molecular sizes of reference bands are indicated in bases (b). Serotypes, PBP types, RFEL types, bars representing the number of isolates per RFEL type, clusters and
cluster codes are also shown. NT, nontypeable; D, RFEL types observed at least once in day care centers. Code “00” refers to untypeable PBP genotypes. Major
serotypes (p) and PBP types (pp) within RFEL types are indicated (for details, see Table 1).
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1). These clusters were Greece specific since they were not
present in the international library. Interestingly, these clusters
consisted of strains that were isolated in day care centers only.
Cluster XIII was mostly observed in a single day care center,
whereas cluster XII was exclusively observed in another day
care center (Fig. 1). Cluster XIII displayed PBP type 2-2-
76 corresponding to low penicillin resistance. Cluster XII
showed a different PBP genotype 2-5-10 with alterations in
pbp2b and pbp2x. None of the latter two PBP genotypes were
present in the international library.
Both study groups were divided in day care center attendees
and non-day care attendees to analyze the contribution of day
care center attendance on clustering of pneumococcal strains.
We observed that 86% of the strains from the day care center
group containing 45 pneumococcal isolates belonged to a clus-
ter. Within the non-day care center group representing 100
pneumococcal isolates, 80% of the strains demonstrated ge-
netic clustering. There was no statistical difference between the
two groups. We reanalyzed our data for the largest day care
center in Patras, where 21 strains were isolated. We observed
that 19 of these 21 strains (90%) clustered within four clusters.
Although this percentage demonstrated a higher degree of
genetic clustering in children attending day care centers, this
difference was statistically not significant.
DISCUSSION
Serotyping of the penicillin-nonsusceptible isolates revealed
that 79% of the Greek strains belonged to serotypes 23F, 23A,
19F, and 19A (40, 41; Syrogiannopoulos et al., unpublished).
These data correspond to earlier findings in other European
countries and in the Americas in which these serogroups also
significantly contributed to the prevalence of penicillin-resis-
tant S. pneumoniae among young carriers (2, 3, 15, 23, 33, 42).
RFEL genotyping of the 145 penicillin-nonsusceptible iso-
lates showed that 82% of the strains matched within genetic
clusters. These data suggest that penicillin-resistant pneumo-
cocci rapidly spread among children. This is in line with earlier
findings by Hermans et al., who demonstrated that the degree
of genetic clustering of penicillin-resistant strains in the Neth-
erlands and Thailand is 70 and 74%, respectively, whereas the
degree of genetic clustering among Dutch penicillin-suscepti-
ble isolates is 32% (21). Similar data have been reported in
various other parts of the world, including Europe, the United
States, and South America (8, 20, 26, 42).
The present study clearly demonstrates the significant con-
tribution of the pandemic clone Spain23F-1 to the prevalence
and spread of penicillin-nonsusceptible pneumococci among
young children in Greece. This is in agreement with studies in
other countries in which the predominance of this pandemic
clone has also been observed (8, 26, 42). In addition, in the
latter studies a second predominant clone, the pandemic clone
France9V-3, was highly contributive to the penicillin-resistant
pneumococcal population. This clone is also present in our
Greek collection, but it does not play a predominant role.
Serogroup 19 represented the major serotype among five
lineages. The lineages of cluster VI and cluster VII represent-
ed mainly multidrug-resistant isolates and were closely related
to isolates found in The Netherlands, Thailand, and Vietnam.
Multilocus sequence typing (MLST) has demonstrated that
cluster VII also matches with multidrug-resistant serotype 19F
isolates from Taiwan (B. Spratt, personal communication).
The three other lineages, representing clusters I and II, clus-
ters III, IV, and V, and cluster XI, respectively, showed inter-
mediate resistance to penicillin only and displayed new PBP
genotypes with alterations in pbp2x only. MLST has demon-
strated that clusters III, IV, and V match with a drug-suscep-
tible serotype 19A invasive isolate from the United Kingdom.
In general, this study showed a relation between accumulation
of alterations in the three PBP genes and level of penicillin
resistance; high resistance levels were often associated with
changes in the DNA banding patterns of all three PBP genes
(18). In addition, there was also a correlation between multi-
drug resistance and cumulative alterations in all three PBP
genes. This phenomenon is in agreement with the previous
observations of Hermans et al. and is hypothesized to be the
effect of frequent horizontal cotransfer of resistance genes
other than PBP genes in pneumococci with high-level penicillin
resistance (20).
Only one lineage, representing two RFEL clusters of sero-
type 21 and 23F, respectively, was found to be Greece specific
since they were not present in the international data library. In
addition, this lineage was found only in three day care centers.
This is strongly suggestive for the dissemination of pneumo-
coccal clones among day care center attendees within and
between day care centers. MLST typing has recently demon-
strated that this RFEL cluster of serotype 21 matches a drug-
susceptible invasive isolate of serotype 21 in the United King-
dom (B. Spratt, personal communication).
In conclusion, our observations demonstrate a high degree
of genetic clustering among penicillin-nonsusceptible, often
multidrug-resistant pneumococci in young children in Greece,
mainly caused by the spread of a restricted number of penicil-
lin-resistant S. pneumoniae clones. Limiting antibiotic prescrip-
tion and promoting compliance would probably contribute to
TABLE 1. Clusters, serotypes, PBP genotypes, and resistance
patterns of the 145 penicillin-resistant pneumococci isolated from
the nasopharynx of young infants in Greece
Clustera No. of strains/no.of RFEL types
Serotype(s)
(no. of strains)
PBP typeb
(no. of strains)
Resistance
patternc
I 2/2 19F 2-2-77 P
II 2/1 19F P
III 6/2 19A and 19F 2-2-75 P
IV 3/1 19A (2) 2-2-75 P
9V (1) 1-1-1 P
V 2/2 19A 2-2-75 P
2-2-80 P
1/1 23A 2-5-61 PCTS
VI 2/2 19A 7-5-1 P(TE)S
2-1-23 P(TE)S
1/1 19A 7-5-1 PCTS
1/1 23A 2-5-27 PCTS
VII 10/2 19F 1(0)-3-30(0) PTE(S)
VIII 2/1 23F 2-2-71 PCT
25-3-1 PS
IX 32/2 23F 1-1-1 PCTECLS
X 33/2 23F (32) PCTS
19F (1) PCTS
1/1 23F PCTES
XI 2/1 19A 2-2-75 PS
2/2 19A PS
XII 2/2 23F 2-5-10 P
XIII 6/1 21 (5) 2-2-76 P
2/2 23F 5-5-10 P
XIV 4/2 15 2-19-57 (2) P
20-19-57 (2) P
XV 8/2 9V, 14, and 23A 1-1-1 P(CT)S
XVI 3/2 23A and 14 PS
a Genetic clustering according to RFEL typing exclusively matched with BOX
PCR fingerprinting.
b Code “(0)” refers to untypeable PBP genotypes.
c The antibiotic resistance pattern was evaluated for penicillin (P), erythromy-
cin (E), chloramphenicol (C), tetracycline (T), clindamycin (CL) and sulfame-
thoxazole-trimethoprim (S).
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the control this problem. A better alternative to prevent the
spread of multidrug resistant clones in the near future, how-
ever, is large-scale vaccination using pneumococcal conjugate
vaccines. Although the initial results of the conjugate vaccina-
tion trials look promising (5, 24; R. Dagan, N. Givon, P. Yagup-
sky, et al., Abstr. 38th Intersci. Conf. Antimicrob. Agents Che-
mother., abstr. G552, 1998), the epidemiological consequences
of such strategies need to be monitored in detail.
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